Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools
Simply Wall St reports Cellebrite (CLBT) shares rose about 3% after results despite a prior 30% drop. Q2 revenue was US$131.1m (up from US$113.3m), while ARR was US$508m (up from US$420m). Management raised full-year adjusted EBITDA margin guidance to the high 20s but trimmed ARR outlook to US$550m to US$560m.
How this was made
The 30-second read
Why it matters
Investors shifted focus from a near-term miss to internal expectations toward the reported ARR level ($508m) and higher full-year adjusted EBITDA margin guidance (high 20s), but the narrative is cooled by guidance cuts and weaker net income/EPS.
Market read
This is a single-name earnings/guidance update that can drive near-term positioning: ARR growth and margin guidance support, while trimmed ARR outlook and earnings quality concerns limit conviction.
What to watch
The article highlights sequential ARR drivers (Guardian, Advanced Unlocks) and Genesis ARR post-launch; traders may want to track whether these products sustain net new ARR and improve Insights conversion uplift.
Background
The stock had been down about 30% over the past month and quarter before the first trading day after results.
Ticker impact
Cellebrite reported Q2 revenue of $131.1m and ARR of $508m, while lifting full-year adjusted EBITDA margin guidance into the high 20s.
Choppy to mildly positive follow-through is plausible, but upside likely capped until investors see improved H2 net new ARR and conversion uplift.
The article cites ARR growth (21%) and higher EBITDA margin guidance, offset by trimmed ARR outlook to $550m-$560m, revenue/ARR misses vs internal expectations, and lower net income/EPS.
Market effects
Reinforces the market’s preference for recurring revenue plus margin discipline in digital intelligence/software, while punishing growth shortfalls versus internal expectations.
No specific regional market impact beyond U.S. Federal and Defense & Intelligence ARR growth mentioned.
Limited; the article focuses on company-specific ARR mix, margins, and guidance rather than global macro or cross-border demand shifts.
Counterpoint
The margin guide lift could be viewed as a temporary cost discipline response, while the trimmed ARR outlook suggests the core growth engine is still under pressure.
Key entities
- companyCellebrite
Digital intelligence platform provider; reported Q2 revenue, ARR, and updated full-year adjusted EBITDA margin guidance, alongside trimmed ARR outlook.
- executiveShiv Ramji
CEO mentioned as part of the post-results context, alongside concerns about forecasting credibility.
